1.5/5
Very weak
evidence
Fat loss evidence brief
Yohimbine / yohimbe
Fat-loss and performance evidence is too limited for recommendation, while stimulant-like safety and product-label risks are material.
Headline Finding
Limited body-composition data are outweighed by stimulant, blood-pressure, interaction, and label-accuracy concerns.
Dose Context
Clinical yohimbine dosing cannot be assumed from yohimbe bark supplements because alkaloid content varies.
Important Caveat
Blood pressure, anxiety, arrhythmia, seizure, medication, and product-quality concerns are central to the verdict.
Source Drawer
Linked Research
- Review Ergogenic review
- Trial Soccer body-composition trial
- Trial Sprint performance trial
- Review Clinical review
- Safety NCCIH safety overview
How To Read This Rating
The score reflects evidence that the supplement does its stated job. Some jobs are direct, such as strength, endurance, or recovery; others are indirect, such as sleep, mood, appetite, or health support. A real effect can still receive a cautious practical rating when dose, safety, product quality, or audience fit remain uncertain.
Spot An Evidence Issue?
Send the disputed claim, source link, and why it changes the practical verdict. Corrections that materially affect the claim, dose, caveat, or rating are prioritized.
Report a source or rating issue